Background. The accumulation of intracellular sodium during myocardial ischemia couples an inappropriate calcium influx and depressed cardiac recovery during subsequent reperfusion. The effects of the selective sodium/hydrogen exchange inhibitor HOE 694 are evaluated during myocardial ischemia and reperfusion.
I
n this study, we investigate the potential protective effects of sodium/hydrogen (Na/H) antiporter inhibition during cardiac ischemia. Cessation of coronary blood flow during cardiac operations renders the myocardium susceptible to ischemic and reperfusion injury. Depletion of high-energy phosphates, production of oxygen radical species, and calcium-induced injury combined with acidosis contribute to cardiac dysfunction [1] . The Na/H antiporter plays a key role in pH regulation and increased intracellular sodium levels during myocardial ischemia [2] . Sodium/hydrogen antiporter activity couples intracellular acidosis with the accumulation of intracellular sodium by extruding hydrogen ions in exchange for sodium. Sodium accumulation is linked to inappropriate calcium influx by an exchanger mechanism through the sodium/calcium channel, resulting in the reciprocal rise of cytosolic calcium, especially during reperfusion, with subsequent ultrastructural damage This study investigates the effects of this specific Na/H exchange inhibitor (HOE 694) during ischemia and reperfusion of an isolated rat heart. The technique of triple quantum filtered (TQF) 23 Na nuclear magnetic resonance (NMR) spectroscopy is used to continuously monitor intracellular sodium levels. Our experiments test the following hypothesis: the addition of HOE 694 to cardioplegic solution attenuates the increase of intracellular sodium during myocardial ischemia and results in improved recovery of contractile function. The potential benefits of Na/H exchange inhibition during cardiac ischemia will be evaluated.
Material and Methods

Isolated Heart Preparation (Nonworking Heart Model)
Ten adult male Sprague-Dawley rats weighing 250 to 300 g were anesthetized with 75 to 100 mg/kg of sodium pentobarbital and anticoagulated with 1,000 United States Pharmacopeia U/kg of heparin sodium by intraperitoneal injection. Hearts were excised through a bilateral thoracotomy and immersed in ice-cold perfusion buffer. Each heart was immediately mounted on the perfusion cannula, and the aorta was perfused retrograde according to the Langendorff method (nonrecirculating). Perfusion was maintained at a constant aortic root pressure of 80 cm [17] . Each observation point of 192 acquisitions required 1.5 minutes. The NMR TQF peak intensities were used to monitor the kinetics of sodium time-course changes. The TQF sodium NMR signal from each heart was normalized to the average preischemic value.
Experimental Protocol
The TQF sodium signal from the heart contains an extracellular component of 73% Ϯ 5% relative to the total preischemic signal [17] . The value was determined by washout experiments of extracellular sodium with icecold 350 mmol/L sucrose and 5 mmol/L histidine (pH 7.4) solution before ischemia and after different durations of ischemia [17, 22] . This observation is consistent with the results of Dizon and co-workers [18] , who estimate the extracellular component of the TQF sodium signal to be 75%. The TQF signal is approximately ten times more sensitive to changes in intracellular sodium than extracellular sodium [17] . Thus, small variations in extracellular sodium are attenuated in the resulting TQF signal. The extracellular sodium concentration is determined primarily by the perfusate solution and is independent of the heart's condition. Therefore, the extracellular component is expected to remain relatively constant during ischemia [ 
Results
Hemodynamic Variables
The addition of 1 mol/L HOE 694 to the cardioplegic solution resulted in significant improvement in the postischemic recovery of left ventricular developed pressure (53.5% Ϯ 8.4% versus 26.4% Ϯ 6.6% [control]; p ϭ 0.036), heart rate (74% Ϯ 3.2% versus 44.2% Ϯ 5.6%; p ϭ 0.002), and rate-pressure product (40.2% Ϯ 6.9% versus 13.2% Ϯ 5%; p ϭ 0.014) after 1 hour of reperfusion. Postischemic recovery of coronary flow was not significantly different between the two groups (68.6% Ϯ 5.9% versus 55.5% Ϯ 4.6%, HOE 694 versus control, respectively; p ϭ 0.11); (Table 1) . Time-dependent changes depicting recovery of left ventricular developed pressure and rate-pressure product indices are illustrated in Figures 1 and 2 .
NMR Sodium Data
The addition of 1 mol/L HOE 694 to the cardioplegic solution attenuated the increase of intracellular sodium during the ischemic interval and during early reperfusion. Intracellular sodium increased to 160.5% Ϯ 9.1% (% preischemic value) at the end of 50 minutes' ischemia in the HOE 694 -treated hearts versus 203.4% Ϯ 10.9% in the control hearts (p ϭ 0.014). During early reperfusion (after the first 30 minutes), intracellular sodium increased to 288.7% Ϯ 10.2% and 335.9% Ϯ 10.3% in the HOE 694 - Table 2) . Timedependent changes in the TQF i NMR sodium signal are depicted in Figure 3 .
During the first 15 minutes of ischemia, the rate of intracellular sodium increase in both groups of hearts was negligible: approximately 0.4%/min (see Fig 3) . We in glycogen-depleted hearts, intracellular sodium accumulation was decreased, leading to less sodium/calcium exchange and improved postischemic recovery. Although cytosolic calcium was not directly measured in this experiment, we presume a correlation between intracellular sodium flux and calcium-induced damage. Monitoring sodium accumulation also gives an indication of sarcolemmal integrity and of the myocyte's ability to sustain energy-dependent processes such as the sarcolemmal Na-K-ATPase pump, which maintains normally low intracellular sodium levels. Increased sodium can also induce myocyte edema. Thus, it is probable that intracellular sodium is a marker of cellular damage as well as a direct and indirect cause of cell injury.
We [17] have previously demonstrated that after 20 minutes of ischemia, intracellular sodium levels return toward baseline during reperfusion in the isolated rat heart. Otherwise, after 40 minutes of ischemia, sodium continues to increase during reperfusion. Harper and Lochner [27] found that after 25 minutes of normothermic ischemia, isolated rat hearts did not recover sarcolemmal permeability, ultrastructure, or function. Malloy and coauthors [24] also observed that the recovery of myocardial function correlated with the return of intracellular sodium levels (measured by NMR) to baseline during reperfusion. During ischemia, intracellular acidosis promotes Na/H antiporter activity, resulting in the progressive rise of intracellular sodium [25] . We have shown an abrupt rise of intracellular sodium accumulation during reperfusion (see Fig 3) Our results indicate that the addition of the specific Na/H exchange inhibitor HOE 694 to cardioplegic solution attenuates the accumulation of intracellular sodium during 50 minutes' normothermic ischemia and during the first 30 minutes of reperfusion. This observation supports the theory that the Na/H antiporter acts as a route for sodium influx. The differential rate of rise of intracellular sodium observed between the two groups of hearts occurs in the last 20 minutes of the ischemic interval, when the rate of sodium accumulation slows considerably in the HOE 694 -treated group. This suggests that Na/H exchange inhibition affects cellular processes late in ischemia. This phenomenon may be due to increasing intracellular acidosis driving Na/H exchange. Thus, in this model, the effects of Na/H exchange inhibition are observed during prolonged ischemia.
This study also demonstrates that HOE 694 treatment improves recovery of postischemic myocardial contractile function (left ventricular developed pressure, heart rate, and rate-pressure product) while having no significant effect on coronary flow. Despite improvement compared with the control group, HOE 694 -treated hearts, functioning well below baseline values, still show signs of significant irreversible damage. We theorize that by lessening the intracellular sodium load, the degree of abrupt calcium influx is decreased, thereby subjecting the myocyte to less potential damage. HOE 694 has been shown to protect rabbit hearts undergoing 12 hours of hypothermic arrest (4°C) [15] . HOE 694 administered during normothermic reperfusion resulted in a more significant recovery of hemodynamic variables than when administered before hypothermic arrest [15] . It is possible that under hypothermic conditions, Na/H exchange activity is minimal, with increased activity during normothermic reperfusion [2] . However, other investigators [12, 14] found that pretreatment with HOE 694 (before ischemia) was most effective in their normothermic ischemic models. The purpose of our experiment was to test the specific Na/H exchange inhibitor as a cardioplegia additive, a route that in clinical use might avoid potential systemic effects of parenteral infusion.
With a decreased sodium load, we presume a subsequent attenuation of the burst introduction of calcium during the crucial early reperfusion period. With potentially less myocyte damage, the heart may be better able to compensate and restore cellular processes. This may be a partial explanation for the decreased intracellular sodium rise observed during early reperfusion in the HOE 694 -treated hearts. Also, it is possible that at the beginning of reperfusion, there may still exist some degree of Na/H exchange inhibition at a time when exchange activity is thought to be increased. These processes augment the recovery of reperfused myocardium. During the last 30 minutes of reperfusion, the intracellular sodium levels continue to increase and are approximately equal between the two groups of hearts, although the HOE 694 -treated hearts show significantly better hemodynamic function. These data suggest improved postischemic recovery as a result of decreased intracellular sodium at the end of the ischemic interval and at the onset of reperfusion.
In conclusion, we have demonstrated that HOE 694 -enhanced cardioplegia did not fully protect hearts from severe injury, as is evident from the observation that despite Na/H exchange inhibition, intracellular sodium continued to rise, and hearts recovered to only 40.2% (rate-pressure product) of their baseline values. By attenuating ionic derangements and subsequent myocellular damage, Na/H exchange inhibitors may confer some benefit during myocardial ischemia and reperfusion. However, sodium and calcium flux have only a partial role in the overall mechanism of ischemic and reperfusion injury. This model, although not typical of the setting of cardiac surgery, demonstrates a reliable method of evaluating the sodium ion changes during myocardial damage and the effects of experimental intervention. The potential efficacy of Na/H inhibitors during cardiac surgical procedures warrants further investigation.
